21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.90.E - Healthcare
2018 | 2019 | ||
---|---|---|---|
M PLN | M PLN | % | |
Assets | 8,6 | 6,7 | -22,2 |
Gross profit (loss) | 3,3 | -0,9 | -128,6 |
EBITDA | 3,2 | -0,5 | -116,2 |
Net profit (loss) | 3,3 | -0,9 | -128,6 |
Cash | 7,9 | 5,2 | -34,5 |
Net income from sale | 0,3 | 0,3 | 5,4 |
Liabilities and provisions for liabilities | 3,5 | 6,6 | 86,3 |
Short time liabilities | 0,3 | 1,7 | 419,1 |
Equity capital | 5,1 | 0,2 | -97 |
Working assets | 8,5 | 5,6 | -34,1 |
Operating profit (EBIT) | 3,2 | -0,8 | -125,5 |
Depreciation | 0 | 0,3 | 19 892,8 |
% | % | p.p. | |
Profitability of capital | 64,4 | -622,7 | -687,1 |
Equity capital to total assets | 59,2 | 2,2 | -57 |
Gross profit margin | 1251,6 | -339,3 | -1590,9 |
EBITDA Margin | 1231,8 | -189,8 | -1421,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 458 | 2257 | 1799 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane